Roivant Sciences (ROIV) Short term Debt (2022 - 2024)
Roivant Sciences' (ROIV) quarterly Short term Debt came in at $12.0 million in Q2 2024, up 63.4% YoY from $7.3 million in Q3 2023, and little changed on a QoQ basis from $12.0 million in Q1 2024.
Roivant Sciences (ROIV) Short term Debt (2022 - 2024) Analysis & Trends
Roivant Sciences (ROIV) has 3 years of Short term Debt data on file, last reported at $12.0 million in Q2 2024.
- Quarterly Short term Debt rose 63.4% year-over-year to $12.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $12.0 million (up 63.4% YoY) and the FY2024 annual result came in at $12.0 million, down 70.53% from the prior year.
- Short term Debt was little changed at $12.0 million in Q2 2024, from $12.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $49.0 million in Q3 2023 to a low of $7.3 million in Q2 2022.
- A 3-year average of $20.8 million and a median of $14.7 million in 2022 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2023 — Short term Debt soared 233.61% — and 2024, when it tumbled 70.53%.
- Tracing ROIV's Short term Debt over 3 years: stood at $22.0 million in 2022, then changed by 0.0% to $22.0 million in 2023, then slumped by 45.53% to $12.0 million in 2024.
- The last three Short term Debt figures came in at $12.0 million (Q2 2024), $12.0 million (Q1 2024), and $22.0 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 22.03 Mn |
| Sep 30, 2023 | 49.00 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 40.72 Mn |
| Dec 31, 2022 | 22.03 Mn |
| Sep 30, 2022 | 14.69 Mn |
| Jun 30, 2022 | 7.34 Mn |